Nuvation Bio Inc. (NUVB) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 83.23M | 41.87M | 13.12M | 4.83M | 3.08M | 5.71M | 727K | 1.44M | 0 | 0 | 0 | 0 |
| Revenue Growth % | 2598.7% | 633.06% | 1704.68% | 236.79% | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 5.62M | 423K | 3.35M | 2.58M | 2.09M | 4.22M | 1.51M | 1.35M | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 6.75% | 1.01% | 25.53% | 53.3% | 67.9% | 73.82% | 208.39% | 93.87% | - | - | - | - |
| Gross Profit | 77.61M | 41.44M | 9.77M | 2.26M | 990K | 1.5M | -788K | 88K | 0 | 0 | 0 | 0 |
| Gross Margin % | 93.25% | 98.99% | 74.47% | 46.7% | 32.1% | 26.18% | -108.39% | 6.13% | - | - | - | - |
| Gross Profit Growth % | 7739.6% | 2672.04% | 1339.97% | 2464.77% | - | - | - | - | - | - | - | - |
| Operating Expenses | 73.73M | 75.48M | 66.2M | 65.85M | 59.99M | 55.44M | 47.31M | 470.47M | 20.2M | 20.83M | 26.34M | 26.13M |
| OpEx % of Revenue | 88.59% | 180.29% | 504.61% | 1362.42% | 1945.33% | 970.71% | 6507.98% | 32785.57% | - | - | - | - |
| Selling, General & Admin | 38.31M | 40.33M | 37.36M | 38.48M | 35.39M | 26.14M | 19.58M | 16.16M | 7.36M | 5.48M | 7.78M | 7.54M |
| SG&A % of Revenue | 46.03% | 96.32% | 284.75% | 796.28% | 1147.63% | 457.68% | 2693.54% | 1125.85% | - | - | - | - |
| Research & Development | 35.05M | 34.3M | 28.85M | 27.36M | 24.6M | 29.3M | 27.73M | 454.32M | 12.84M | 15.35M | 18.56M | 18.59M |
| R&D % of Revenue | 42.11% | 81.92% | 219.86% | 566.15% | 797.7% | 513.03% | 3814.44% | 31659.72% | - | - | - | - |
| Other Operating Expenses | 375K | 856K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 3.88M | -34.04M | -56.43M | -63.59M | -59M | -53.94M | -48.1M | -470.38M | -20.2M | -20.83M | -26.34M | -26.13M |
| Operating Margin % | 4.66% | -81.3% | -430.14% | -1315.73% | -1913.23% | -944.53% | -6616.37% | -32779.44% | - | - | - | - |
| Operating Income Growth % | 106.58% | 36.9% | -17.32% | 86.48% | -192.11% | -158.95% | -82.62% | -1700.1% | 23.84% | 14.4% | 10.22% | 31% |
| EBITDA | 3.88M | -29.92M | -55.9M | -63.23M | -58.69M | -53.72M | -47.94M | -470.14M | -20.14M | -20.78M | -26.28M | -26.07M |
| EBITDA Margin % | 4.66% | -71.47% | -426.07% | -1308.36% | -1903.18% | -940.69% | -6594.09% | -32762.44% | - | - | - | - |
| EBITDA Growth % | 106.61% | 44.31% | -16.61% | 86.55% | -191.42% | -158.58% | -82.39% | -1703.03% | 23.9% | 14.45% | 10.24% | 31.06% |
| D&A (Non-Cash Add-back) | 0 | 0 | 534K | 356K | 310K | 219K | 162K | 244K | 58K | 55K | 55K | 56K |
| EBIT | 0 | -29.92M | -55.29M | -58.59M | -53.18M | -49.36M | -41.09M | -462.36M | -14.79M | -20.83M | -19.65M | -20.64M |
| Net Interest Income | 0 | -1.38M | -501K | 4.36M | 5.27M | 5.97M | 6.61M | 7.01M | 7.13M | 7.02M | 6.52M | 6.09M |
| Interest Income | 5.11M | 5.3M | 0 | 4.78M | 5.32M | 6.06M | 6.73M | 7.14M | 7.13M | 7.02M | 6.52M | 6.09M |
| Interest Expense | -6.71M | 6.67M | 501K | 421K | 54K | 89K | 120K | 132K | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.52M | -2.56M | 642K | 4.58M | 5.77M | 4.5M | 6.89M | 7.89M | 5.41M | 7.04M | 6.69M | 5.49M |
| Pretax Income | 5.4M | -36.59M | -55.79M | -59.01M | -53.24M | -49.45M | -41.21M | -462.49M | -14.79M | -13.79M | -19.65M | -20.64M |
| Pretax Margin % | 6.48% | -87.4% | -425.24% | -1220.92% | -1726.2% | -865.79% | -5668.5% | -32229.41% | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 5.4M | -36.59M | -55.79M | -59.01M | -53.24M | -49.45M | -41.21M | -462.49M | -14.79M | -13.79M | -19.65M | -20.64M |
| Net Margin % | 6.48% | -87.4% | -425.24% | -1220.92% | -1726.2% | -865.79% | -5668.5% | -32229.41% | - | - | - | - |
| Net Income Growth % | 110.14% | 25.99% | -35.38% | 87.24% | -259.9% | -258.63% | -109.73% | -2140.76% | 31.92% | 33.86% | 27.77% | 40.79% |
| Net Income (Continuing) | 5.4M | -36.59M | -55.79M | -59.01M | -53.24M | -49.45M | -41.21M | -462.49M | -14.79M | -13.79M | -19.65M | -20.64M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.01 | -0.11 | -0.16 | -0.17 | -0.16 | -0.15 | -0.15 | -1.89 | -0.07 | -0.06 | -0.09 | -0.09 |
| EPS Growth % | 106.25% | 26.67% | -6.67% | 91.01% | -128.57% | -138.1% | -66.67% | -2000% | 29.51% | 37% | 25% | 43.75% |
| EPS (Basic) | 0.02 | -0.11 | -0.16 | -0.17 | -0.16 | -0.15 | -0.15 | -1.89 | -0.07 | -0.06 | -0.09 | -0.09 |
| Diluted Shares Outstanding | 377.52M | 344.34M | 342.39M | 340.75M | 338.61M | 336.93M | 273.56M | 244.74M | 219.05M | 218.91M | 218.94M | 218.85M |
| Basic Shares Outstanding | 347.33M | 344.34M | 342.39M | 340.75M | 338.61M | 336.93M | 273.56M | 244.74M | 219.05M | 218.91M | 218.94M | 218.85M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |